
Biocartis Group NV
BCART | BR
Overview
Corporate Details
- ISIN(s):
- BE0974281132 (+1 more)
- LEI:
- 549300J4HOJL5KG8HY54
- Country:
- Belgium
- Address:
- GENERAAL DE WITTELAAN 11 BOÎTE B, 2800 MECHELEN
- Website:
- https://www.biocartis.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Biocartis Group NV is an innovative molecular diagnostics company committed to revolutionizing molecular testing. The company develops and commercializes its unique, proprietary Idylla™ platform, a fully automated, real-time PCR-based system designed to provide fast, easy, and actionable molecular diagnostic results. Biocartis' mission is to enable personalized medicine and improve patient outcomes by making molecular testing accessible to any lab, regardless of size or expertise. The company's primary focus is on providing tests for oncology and infectious diseases.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Biocartis Group NV.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2024-01-10 00:00 |
Major Shareholding Notification
BIOCARTIS GROUP NV 2024-01-05 to Issuer (JPM).pdf
|
English | 219.7 KB | |
2024-01-10 00:00 |
Major Shareholding Notification
20240110_Share treshold notification_JPM_ENG.pdf
|
English | 103.6 KB | |
2023-10-03 07:00 |
Declaration of Voting Results & Voting Rights Announcements
JJDC - Biocartis - Transparency Notification Form - Final - 27 September 2023 -…
|
English | 514.6 KB | |
2023-10-03 07:00 |
Major Shareholding Notification
20231003_PR TranspNotification_JJDC_ENG.pdf
|
English | 73.0 KB | |
2023-10-03 07:00 |
Major Shareholding Notification
20231003_PR TranspNotification_JJDC_NL.pdf
|
Dutch | 74.8 KB | |
2023-09-26 07:00 |
Interim Report
MASTER Biocartis H1 2023 Financial Report ENG_FINAL.pdf
|
English | 8.2 MB | |
2023-09-26 07:00 |
Interim Report
Biocartis H1 2023 Financial Report NLD_FINAL.pdf
|
Dutch | 9.5 MB | |
2023-09-26 07:00 |
Earnings Release
20230926 PR H1 2023 Results_ENG.pdf
|
English | 203.5 KB | |
2023-09-26 07:00 |
Earnings Release
20230926 PR H1 2023 Results_NL.pdf
|
Dutch | 204.9 KB | |
2023-07-18 07:00 |
Board/Management Information
20230718_cfo_announcement_eng.pdf
|
English | 112.3 KB | |
2023-07-18 07:00 |
Board/Management Information
20230718_cfo_announcement_nl.pdf
|
Dutch | 75.5 KB | |
2023-06-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
pr_outstanding_shares_june2023_eng.pdf
|
English | 109.9 KB | |
2023-06-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
pr_outstanding_shares_june2023_nl_1.pdf
|
Dutch | 114.9 KB | |
2023-06-20 17:40 |
Declaration of Voting Results & Voting Rights Announcements
230619_pr_transpnotification_ubs_eng.pdf
|
English | 74.9 KB | |
2023-06-20 17:40 |
Declaration of Voting Results & Voting Rights Announcements
230619_pr_transpnotification_ubs_nl.pdf
|
Dutch | 93.3 KB |
Automate Your Workflow. Get a real-time feed of all Biocartis Group NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Biocartis Group NV via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2021-04-29 | Devogelaere Benoit | Executive member | Buy | 15,000 | N/A |
2021-04-28 | Marcofin BV | Executive member | Buy | 30,000 | N/A |
2021-04-27 | Herman Verrelst | Board | Buy | 60,000 | N/A |
2020-11-13 | Devogelaere Benoit | Executive member | Buy | 50,000 | N/A |
2020-05-06 | Herman Verrelst | Board | Buy | 50,000 | 249,625.00 EUR |
2020-05-06 | Herman Verrelst | Board | Buy | 300,000 | N/A |
2020-05-04 | Herman Verrelst | Board | Buy | 46,803 | 231,656.00 EUR |
2020-05-04 | Herman Verrelst | Board | Buy | 3,197 | 15,315.00 EUR |
2019-12-18 | Devogelaere Benoit | Executive member | Buy | 50,000 | N/A |
2019-12-16 | Welten Ewoud | Executive member | Buy | 10,000 | N/A |